Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

A finite mixture survival model to characterize risk groups of neuroblastoma.

Hunsberger S, Albert PS, London WB.

Stat Med. 2009 Apr 15;28(8):1301-14. doi: 10.1002/sim.3543.

PMID:
19184977
[PubMed - indexed for MEDLINE]
2.

[Management strategy in neuroblastoma].

Balwierz W.

Przegl Lek. 2004;61 Suppl 2:3-8. Review. Polish.

PMID:
15686038
[PubMed - indexed for MEDLINE]
3.

Criteria for optimizing prognostic risk groups in pediatric cancer: analysis of data from the Children's Oncology Group.

Sposto R, London WB, Alonzo TA; Children's Oncology Group.

J Clin Oncol. 2007 May 20;25(15):2070-7.

PMID:
17513812
[PubMed - indexed for MEDLINE]
Free Article
4.

A cure Weibull gamma-frailty survival model and its application to exploring the prognosis factors of neuroblastoma.

Dokhi M, Ohtaki M, Hiyama E.

Hiroshima J Med Sci. 2009 Mar;58(1):25-35.

PMID:
19400554
[PubMed - indexed for MEDLINE]
5.

Neuroblastoma: an enigmatic disease.

Brossard J, Bernstein ML, Lemieux B.

Br Med Bull. 1996 Oct;52(4):787-801. Review.

PMID:
9039732
[PubMed - indexed for MEDLINE]
Free Article
6.

Neuroblastoma.

Castleberry RP.

Eur J Cancer. 1997 Aug;33(9):1430-7; discussion 1437-8. Review.

PMID:
9337686
[PubMed - indexed for MEDLINE]
7.

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.

Vandesompele J, Baudis M, De Preter K, Van Roy N, Ambros P, Bown N, Brinkschmidt C, Christiansen H, Combaret V, Lastowska M, Nicholson J, O'Meara A, Plantaz D, Stallings R, Brichard B, Van den Broecke C, De Bie S, De Paepe A, Laureys G, Speleman F.

J Clin Oncol. 2005 Apr 1;23(10):2280-99.

PMID:
15800319
[PubMed - indexed for MEDLINE]
Free Article
8.

Biology and treatment of neuroblastoma.

Castleberry RP.

Pediatr Clin North Am. 1997 Aug;44(4):919-37. Review.

PMID:
9286292
[PubMed - indexed for MEDLINE]
9.

Neuroblastoma: biology and staging.

Mueller S, Matthay KK.

Curr Oncol Rep. 2009 Nov;11(6):431-8. Review.

PMID:
19840520
[PubMed - indexed for MEDLINE]
10.

High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma.

Fredlund E, Ringnér M, Maris JM, Påhlman S.

Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14094-9. doi: 10.1073/pnas.0804455105. Epub 2008 Sep 9.

PMID:
18780787
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

[Neuroblastoma].

Simon T.

Urologe A. 2005 May;44(5):543-54; 555. Review. German.

PMID:
15856156
[PubMed - indexed for MEDLINE]
12.

Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction.

Schramm A, Mierswa I, Kaderali L, Morik K, Eggert A, Schulte JH.

Cancer Lett. 2009 Sep 8;282(1):55-62. doi: 10.1016/j.canlet.2009.02.052. Epub 2009 Apr 5.

PMID:
19349112
[PubMed - indexed for MEDLINE]
13.

Neuroblastoma in the very young child: biological considerations.

Kemshead JT, Patel K, Phimister B.

Br J Cancer Suppl. 1992 Aug;18:S102-5. Review.

PMID:
1503919
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Current aspects of biology, risk assessment, and treatment of neuroblastoma.

Haase GM, Perez C, Atkinson JB.

Semin Surg Oncol. 1999 Mar;16(2):91-104. Review.

PMID:
9988866
[PubMed - indexed for MEDLINE]
15.

Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratification.

Hiyama E, Yamaoka H, Kondo S, Yoneda A, Tajiri T, Fukuzawa M, Sugiyama M, Hayashi Y, Sasaki F, Ohtaki M.

Pediatr Surg Int. 2007 Nov;23(11):1051-8. Epub 2007 Aug 16.

PMID:
17701415
[PubMed - indexed for MEDLINE]
16.

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK; INRG Task Force.

J Clin Oncol. 2009 Jan 10;27(2):289-97. doi: 10.1200/JCO.2008.16.6785. Epub 2008 Dec 1.

PMID:
19047291
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Neuroblastoma: biological insights into a clinical enigma.

Brodeur GM.

Nat Rev Cancer. 2003 Mar;3(3):203-16. Review.

PMID:
12612655
[PubMed - indexed for MEDLINE]
18.

Neuroblastoma: treatment outcome after incomplete resection of primary tumors.

Moon SB, Park KW, Jung SE, Youn WJ.

Pediatr Surg Int. 2009 Sep;25(9):789-93. doi: 10.1007/s00383-009-2417-8. Epub 2009 Jul 21.

PMID:
19629500
[PubMed - indexed for MEDLINE]
19.

Neuroblastoma: biology, prognosis, and treatment.

Park JR, Eggert A, Caron H.

Pediatr Clin North Am. 2008 Feb;55(1):97-120, x. doi: 10.1016/j.pcl.2007.10.014. Review.

PMID:
18242317
[PubMed - indexed for MEDLINE]
20.

Neuroblastoma: a disease requiring a multitude of imaging studies.

Kushner BH.

J Nucl Med. 2004 Jul;45(7):1172-88. Review.

PMID:
15235064
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk